Question from Deputy Ken O’Flynn - PQ 38768-26
Deputy O'Flynn asked about the environmental impact of unused or expired medicines. Read the HSE response.
- Published date:
- :
Corporate publications
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Showing 1061 to 1070 of 6813 results
Question from Deputy Ken O’Flynn - PQ 38770-26
Deputy O'Flynn asked whether the HSE reimburses medicines which are dispensed but never collected by patients. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O’Flynn - PQ 38771-26
Deputy O'Flynn asked about medication reviews for patients on multiple prescriptions. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O’Flynn - PQ 38764-26
Deputy O'Flynn asked if the HSE records the quantity and estimated value of unused or expired medicines returned to community pharmacies. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O’Flynn - PQ 38765-26
Deputy O'Flynn asked about the policy measures that are currently in place to reduce avoidable medicines waste. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O’Flynn - PQ 38767-26
Deputy O'Flynn asked if the HSE has a national medicines waste reduction strategy. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O’Flynn - PQ 38847-26
Deputy O'Flynn asked about the reimbursement consideration for omaveloxolone (skyclarys). Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 39205-26
Deputy O'Flynn asked if a patient safety governance framework exists governing procedures funded under the treatment abroad scheme. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 39193-26
Deputy O'Flynn asked if certain procedures funded abroad under the treatment abroad scheme could be developed domestically. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O’Flynn - PQ 38849-26
Deputy O'Flynn asked how are reimbursement decisions for high-cost orphan medicines are financially planned. Read the HSE response.
- Published date:
- :